ASCIRES

ASCIRES is a pioneering biomedical group in Spain specializing in Imaging Diagnostics, Nuclear Medicine, and Image-guided Radiotherapeutic Oncology. The company, founded in 2010, has positioned itself as a leader in the fields of Imaging Diagnosis, Nuclear Medicine, and Medical Genetics, as well as a reference in Radiotherapeutic Oncology. With a 60-year track record and a team of over 600 professionals, Ascires serves both public and private hospitals, along with operating its own network of Biomedical Clinics in the Valencian Community and Catalonia. The company's primary focus lies in diagnosis and treatment, with an annual reinvestment of 20% of its profits in R&D. This reinvestment is directed towards precision personalized medicine, with a strong emphasis on ongoing innovation in the development of artificial intelligence biomarkers and proprietary diagnostic algorithms. Ascires operates within the Health Care and Medical Devices industries. As of the latest available information, there is no record of the company's recent investment or the involved investors. ASCIRES's mission, dedication to innovation, and extensive industry expertise demonstrate its potential for remarkable growth and impact within the biomedical sector.